| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.42 | 0.01 |